-
1
-
-
33746310315
-
Alzheimer's disease
-
DOI 10.1016/S0140-6736(06)69113-7, PII S0140673606691137
-
Blennow K, de Leon MJ, Zetterberg H (2006) Alzheimer's disease. Lancet 368, 387-403. (Pubitemid 44108123)
-
(2006)
Lancet
, vol.368
, Issue.9533
, pp. 387-403
-
-
Blennow, K.1
De Leon, M.J.2
Zetterberg, H.3
-
2
-
-
33745027879
-
Molecular mechanisms for Alzheimer's disease: Implications for neuroimaging and therapeutics
-
DOI 10.1111/j.1471-4159.2006.03989.x
-
Masters CL, Cappai R, Barnham KJ, Villemagne VL (2006) Molecular mechanisms for Alzheimer's disease: Implications for neuroimaging and therapeutics. J Neurochem 97, 1700- 1725. (Pubitemid 43873662)
-
(2006)
Journal of Neurochemistry
, vol.97
, Issue.6
, pp. 1700-1725
-
-
Masters, C.L.1
Cappai, R.2
Barnham, K.J.3
Villemagne, V.L.4
-
4
-
-
34447322271
-
Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria
-
DOI 10.1016/S1474-4422(07)70178-3, PII S1474442207701783
-
Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger- Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G,Meguro K, O'brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P (2007) Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol 6, 734-746. (Pubitemid 47058377)
-
(2007)
Lancet Neurology
, vol.6
, Issue.8
, pp. 734-746
-
-
Dubois, B.1
Feldman, H.H.2
Jacova, C.3
Dekosky, S.T.4
Barberger-Gateau, P.5
Cummings, J.6
Delacourte, A.7
Galasko, D.8
Gauthier, S.9
Jicha, G.10
Meguro, K.11
O'Brien, J.12
Pasquier, F.13
Robert, P.14
Rossor, M.15
Salloway, S.16
Stern, Y.17
Visser, P.J.18
Scheltens, P.19
-
5
-
-
0028169925
-
Visualization of A-42(43) and A-40 in senile plaques with end-specific A- monoclonals: Evidence that an initially deposited species is A-42(43)
-
Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina H, Ihara Y (1994) Visualization of A-42(43) and A-40 in senile plaques with end-specific A- monoclonals: Evidence that an initially deposited species is A-42(43). Neuron 13, 45-53.
-
(1994)
Neuron
, vol.13
, pp. 45-53
-
-
Iwatsubo, T.1
Odaka, A.2
Suzuki, N.3
Mizusawa, H.4
Nukina, H.5
Ihara, Y.6
-
6
-
-
65249159879
-
Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
-
Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter W, Lee VM, Trojanowski JQ (2009) Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann Neurol 65, 403-413.
-
(2009)
Ann Neurol
, vol.65
, pp. 403-413
-
-
Shaw, L.M.1
Vanderstichele, H.2
Knapik-Czajka, M.3
Clark, C.M.4
Aisen, P.S.5
Petersen, R.C.6
Blennow, K.7
Soares, H.8
Simon, A.9
Lewczuk, P.10
Dean, R.11
Siemers, E.12
Potter, W.13
Lee, V.M.14
Trojanowski, J.Q.15
-
7
-
-
61449261038
-
Alzheimer's Disease Neuroimaging Initiative: A one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition
-
Leow AD, Yanovsky I, Parikshak N, Hua X, Lee S, Toga AW, Jack CR Jr, Bernstein MA, Britson PJ, Gunter JL, Ward CP, Borowski B, Shaw LM, Trojanowski JQ, Fleisher AS, Harvy D, Kornak J, Schuff N, Alexander GE, Weiner MW, Thompson PM (2009) Alzheimer's Disease Neuroimaging Initiative: A one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition. Neuroimage 45, 645-655.
-
(2009)
Neuroimage
, vol.45
, pp. 645-655
-
-
Leow, A.D.1
Yanovsky, I.2
Parikshak, N.3
Hua, X.4
Lee, S.5
Toga, A.W.6
Jack Jr., C.R.7
Bernstein, M.A.8
Britson, P.J.9
Gunter, J.L.10
Ward, C.P.11
Borowski, B.12
Shaw, L.M.13
Trojanowski, J.Q.14
Fleisher, A.S.15
Harvy, D.16
Kornak, J.17
Schuff, N.18
Alexander, G.E.19
Weiner, M.W.20
Thompson, P.M.21
more..
-
8
-
-
0021271971
-
Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease
-
McKhann G, Drachman DA, Folstein M, Katzman R, Price DL, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease - report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34, 939-944. (Pubitemid 14076461)
-
(1984)
Neurology
, vol.34
, Issue.7
, pp. 939-944
-
-
McKhann, G.1
Drachman, D.2
Folstein, M.3
-
9
-
-
80054740636
-
QUADAS-2: A revised tool for the quality assessment of diagnostic accuracy studies
-
Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM (2011) QUADAS-2: A revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155, 529-536.
-
(2011)
Ann Intern Med
, vol.155
, pp. 529-536
-
-
Whiting, P.F.1
Rutjes, A.W.2
Westwood, M.E.3
Mallett, S.4
Deeks, J.J.5
Reitsma, J.B.6
Leeflang, M.M.7
Sterne, J.A.8
Bossuyt, P.M.9
-
10
-
-
0001802176
-
Some common problems in medical research
-
9th ed. Altman DG, ed. Chapman, London
-
Altman DG (1999) Some common problems in medical research. In: Practical Statistics for Medical Research, 9th ed. Altman DG, ed. Chapman, London, pp. 396-439.
-
(1999)
Practical Statistics for Medical Research
, pp. 396-439
-
-
Altman, D.G.1
-
11
-
-
0028316145
-
Guidelines for meta-analyses evaluating diagnostic tests
-
Irwig L, Tosteson AN, Gatsonis C, Lau J, Colditz G, Chalmers TC, Mosteller F (1994) Guidelines for meta-analyses evaluating diagnostic tests. Ann Intern Med 120, 667-676. (Pubitemid 24106180)
-
(1994)
Annals of Internal Medicine
, vol.120
, Issue.8
, pp. 667-676
-
-
Irwig, L.1
Tosteson, A.N.A.2
Gatsonis, C.3
Lau, J.4
Colditz, G.5
Chalmers, T.C.6
Mosteller, F.7
-
12
-
-
24944498883
-
Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews
-
DOI 10.1016/j.jclinepi.2005.02.022, PII S0895435605001629
-
Reitsma JB, Glas AS, Rutjes AWS, Scholten R, Bossuy PM, Zwinderman AH (2005) Bivariate analysis of sensitivity and specificity produce informative summary measures in diagnostic reviews. J Clin Epidemiol 58, 982-990. (Pubitemid 41316441)
-
(2005)
Journal of Clinical Epidemiology
, vol.58
, Issue.10
, pp. 982-990
-
-
Reitsma, J.B.1
Glas, A.S.2
Rutjes, A.W.S.3
Scholten, R.J.P.M.4
Bossuyt, P.M.5
Zwinderman, A.H.6
-
13
-
-
33746630447
-
Meta-analysis of diagnostic and screening test accuracy evaluations: Methodologic primer
-
DOI 10.2214/AJR.06.0226
-
Gatsonis C, Paliwal P (2006) Meta-analysis of diagnostic and screening test accuracy evaluations: Methodologic primer. AJR Am J Roentgenol 187, 271-281. (Pubitemid 44148267)
-
(2006)
American Journal of Roentgenology
, vol.187
, Issue.2
, pp. 271-281
-
-
Gatsonis, C.1
Paliwal, P.2
-
14
-
-
23644432857
-
The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed
-
DOI 10.1016/j.jclinepi.2005.01.016, PII S0895435605001423
-
Deeks JJ, Macaskill P, Irwig L (2005) The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol 58, 882e93. (Pubitemid 41115772)
-
(2005)
Journal of Clinical Epidemiology
, vol.58
, Issue.9
, pp. 882-893
-
-
Deeks, J.J.1
Macaskill, P.2
Irwig, L.3
-
16
-
-
33747851721
-
Meta-DiSc: A software for meta-analysis of test accuracy data
-
Zamora J AV, Muriel A, Khan KS, Coomarasamy A (2006) Meta-DiSc: A software for meta-analysis of test accuracy data. BMC Med Res Method 6, 31.
-
(2006)
BMC Med Res Method
, vol.6
, pp. 31
-
-
Zamora, J.A.V.1
Muriel, A.2
Khan, K.S.3
Coomarasamy, A.4
-
17
-
-
79952763791
-
Chapter 9: Assessing methodological quality
-
Deek JJ, Bossuyt PM, Gatsonis C, eds. The Cochrane Collaboration Accessed 19 July 2013
-
Reitsma JB, Rujes AW, Whiting P, Vlassov VV, Leeflang MM, Deeks JJ (2009) Chapter 9: Assessing methodological quality. In Cochrane Handobook for Systematic Review of Diagnostic Test Accuracy, Version 1.0.0. Deek JJ, Bossuyt PM, Gatsonis C, eds. The Cochrane Collaboration, http://srdta.cochrane.org/ handbook-dta-reviews, Accessed 19 July 2013.
-
(2009)
Cochrane Handobook for Systematic Review of Diagnostic Test Accuracy, Version 1.0.0
-
-
Reitsma, J.B.1
Rujes, A.W.2
Whiting, P.3
Vlassov, V.V.4
Leeflang, M.M.5
Deeks, J.J.6
-
18
-
-
0033061647
-
Cerebrospinal fluid -amyloid((1-42)) in Alzheimer disease: Differences between early- and late-onset Alzheimer disease and stability during the course of disease
-
DOI 10.1001/archneur.56.6.673
-
Andreasen N, Hesse C, Davidsson P, Minthon L, Wallin A, Winblad B, Vanderstichele H, Vanmechelen E, Blennow K (1999) Cerebrospinal fluid beta-amyloid (1-42) in Alzheimer disease: Differences between early- and late-onset Alzheimer disease and stability during the course of disease. Arch Neurol 56, 673-680. (Pubitemid 29266465)
-
(1999)
Archives of Neurology
, vol.56
, Issue.6
, pp. 673-680
-
-
Andreasen, N.1
Hesse, C.2
Davidsson, P.3
Minthon, L.4
Wallin, A.5
Winblad, B.6
Vanderstichele, H.7
Vanmechelen, E.8
Blennow, K.9
-
19
-
-
0035108753
-
Evaluation of CSF-tau and CSF-A42 as diagnostic markers for Alzheimer disease in clinical practice
-
Andreasen N, Minthon L, Davidsson P, Vanmechelen E, Vanderstichele H, Winblad B, Blennow K (2001) Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice. Arch Neurol 58, 373- 379. (Pubitemid 32217453)
-
(2001)
Archives of Neurology
, vol.58
, Issue.3
, pp. 373-379
-
-
Andreasen, N.1
Minthon, L.2
Davidsson, P.3
Vanmechelen, E.4
Vanderstichele, H.5
Winblad, B.6
Blennow, K.7
-
20
-
-
0037244487
-
Cerebrospinal fluid levels of totaltau, phospho-tau and A beta 42 predicts development of Alzheimer's disease in patients with mild cognitive impairment
-
Andreasen N, Vanmechelen E, Vanderstichele H, Davidsson P, Blennow K (2003) Cerebrospinal fluid levels of totaltau, phospho-tau and A beta 42 predicts development of Alzheimer's disease in patients with mild cognitive impairment. Acta Neurol Scand Suppl 179, 47-51.
-
(2003)
Acta Neurol Scand Suppl
, vol.179
, pp. 47-51
-
-
Andreasen, N.1
Vanmechelen, E.2
Vanderstichele, H.3
Davidsson, P.4
Blennow, K.5
-
21
-
-
33750455449
-
CSF diagnosis of Alzheimer's disease and dementia with Lewy bodies
-
DOI 10.1007/s00702-006-0537-z, 100 Years of Alzheimer's Disease
-
Bibl M, Mollenhauer B, Esselmann H, Lewczuk P, Trenkwalder C, Brechlin P, R?uther E, Kornhuber J, Otto M, Wiltfang J (2006) CSF diagnosis of Alzheimer's disease and dementia with Lewybodies. J Neural Transm 113, 1771-1778. (Pubitemid 44657673)
-
(2006)
Journal of Neural Transmission
, vol.113
, Issue.11
, pp. 1771-1778
-
-
Bibl, M.1
Mollenhauer, B.2
Esselmann, H.3
Lewczuk, P.4
Trenkwalder, C.5
Brechlin, P.6
Ruther, E.7
Kornhuber, J.8
Otto, M.9
Wiltfang, J.10
-
22
-
-
34347272662
-
Validation of amyloid- peptides in CSF diagnosis of neurodegenerative dementias
-
DOI 10.1038/sj.mp.4001967, PII 4001967
-
Bibl M, Mollenhauer B, Lewczuk P, Esselmann H, Wolf S, Trenkwalder C, Otto M, Stiens G, R?uther E, Kornhuber J, Wiltfang J (2007) Validation of amyloid-beta peptides in CSF diagnosis of neurodegenerative dementias. Mol Psychiatry 12, 671-680. (Pubitemid 46998250)
-
(2007)
Molecular Psychiatry
, vol.12
, Issue.7
, pp. 671-680
-
-
Bibl, M.1
Mollenhauer, B.2
Lewczuk, P.3
Esselmann, H.4
Wolf, S.5
Trenkwalder, C.6
Otto, M.7
Stiens, G.8
Ruther, E.9
Kornhuber, J.10
Wiltfang, J.11
-
23
-
-
33746641249
-
42/phosphorylated tau ratio discriminates between Alzheimer's disease and vascular dementia
-
de Jong D, Jansen RW, Kremer BP, Verbeek MM (2006) Cerebrospinal fluid amyloid beta42/phosphorylated tau ratio discriminates between Alzheimer's disease and vascular dementia. J Gerontol A Biol Sci Med Sci 61, 755-758. (Pubitemid 44148364)
-
(2006)
Journals of Gerontology - Series A Biological Sciences and Medical Sciences
, vol.61
, Issue.7
, pp. 755-758
-
-
De Jong, D.1
Jansen, R.W.M.M.2
Kremer, B.P.H.3
Verbeek, M.M.4
-
24
-
-
77955453909
-
Alzheimer's Disease Neuroimaging Initiative. Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people
-
De Meyer G, Shapiro F, Vanderstichele H, Vanmechelen E, Engelborghs S, De Deyn PP, Coart E, Hansson O, Minthon L, Zetterberg H, Blennow K, Shaw L, Trojanowski JQ (2010) Alzheimer's Disease Neuroimaging Initiative. Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people. Arch Neurol 67, 949-956.
-
(2010)
Arch Neurol
, vol.67
, pp. 949-956
-
-
De Meyer, G.1
Shapiro, F.2
Vanderstichele, H.3
Vanmechelen, E.4
Engelborghs, S.5
De Deyn, P.P.6
Coart, E.7
Hansson, O.8
Minthon, L.9
Zetterberg, H.10
Blennow, K.11
Shaw, L.12
Trojanowski, J.Q.13
-
25
-
-
15644363081
-
High cerebrospinal fluid tau and low amyloid 42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein e genotype
-
DOI 10.1001/archneur.55.7.937
-
Galasko D, Chang L, Motter R, Clark CM, Kaye J, Knopman D, Thomas R, Kholodenko D, Schenk D, Lieberburg I, Miller B, Green R, Basherad R, Kertiles L, Boss MA, Seubert P (1998) High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype. Arch Neurol 55, 937-945. (Pubitemid 28335112)
-
(1998)
Archives of Neurology
, vol.55
, Issue.7
, pp. 937-945
-
-
Galasko, D.1
Chang, L.2
Motter, R.3
Clark, C.M.4
Kaye, J.5
Knopman, D.6
Thomas, R.7
Kholodenko, D.8
Schenk, D.9
Lieberburg, I.10
Miller, B.11
Green, R.12
Basherad, R.13
Kertiles, L.14
Boss, M.A.15
Seubert, P.16
-
26
-
-
0142027660
-
CSF-tau, CSF-A1-42, ApoE-genotype and clinical parameters in the diagnosis of Alzheimer's disease: Combination of CSF-tau and MMSE yields highest sensitivity and specificity
-
DOI 10.1007/s00702-003-0017-7
-
Ganzer S, Arlt S, Schoder V, Buhmann C, Mandelkow EM, Finckh U, Beisiegel U, Naber D, M?uller-Thomsen T (2003) CSF-tau, CSF-Abeta1-42, ApoE-genotype and clinical parameters in the diagnosis of Alzheimer's disease: Combination of CSF-tau andMMSEyields highest sensitivity and specificity. J Neural Transm 110, 1149-1160. (Pubitemid 37271858)
-
(2003)
Journal of Neural Transmission
, vol.110
, Issue.10
, pp. 1149-1160
-
-
Ganzer, S.1
Arlt, S.2
Schoder, V.3
Buhmann, C.4
Mandelkow, E.-M.5
Finckh, U.6
Beisiegel, U.7
Naber, D.8
Muller-Thomsen, T.9
-
27
-
-
78651269012
-
A-40 oligomers identified as a potential biomarker for the diagnosis of Alzheimer's disease
-
Gao CM,YamAY,Wang X, Magdangal E, Salisbury C, Peretz D, Zuckermann RN, Connolly MD, Hansson O, Minthon L, Zetterberg H, Blennow K, Fedynyshyn JP, Allauzen S (2010) A-40 oligomers identified as a potential biomarker for the diagnosis of Alzheimer's disease. PLoS One 5, e15725.
-
(2010)
PLoS One
, vol.5
-
-
Gao, C.M.1
Yam, A.Y.2
Wang, X.3
Magdangal, E.4
Salisbury, C.5
Peretz, D.6
Zuckermann, R.N.7
Connolly, M.D.8
Hansson, O.9
Minthon, L.10
Zetterberg, H.11
Blennow, K.12
Fedynyshyn, J.P.13
Allauzen, S.14
-
28
-
-
78650464378
-
Evaluation of CSF biomarkers as predictors of Alzheimer's disease: A clinical follow-up study of 4.7 years
-
Hertze J, Minthon L, Zetterberg H, Vanmechelen E, Blennow K, Hansson O (2010) Evaluation of CSF biomarkers as predictors of Alzheimer's disease: A clinical follow-up study of 4.7 years. J Alzheimers Dis 21, 1119-1128.
-
(2010)
J Alzheimers Dis
, vol.21
, pp. 1119-1128
-
-
Hertze, J.1
Minthon, L.2
Zetterberg, H.3
Vanmechelen, E.4
Blennow, K.5
Hansson, O.6
-
29
-
-
44649183443
-
Prediction of Alzheimer's disease using a cerebrospinal fluid pattern of C-terminally truncated -amyloid peptides
-
DOI 10.1159/000119457
-
H?oglund K, Hansson O, Buchhave P, Zetterberg H, Lewczuk P, Londos E, Blennow K, Minthon L, Wiltfang J (2008) Prediction of Alzheimer's disease using a cerebrospinal fluid pattern of C-terminally truncated beta-amyloid peptides. Neurodegener Dis 5, 268-276. (Pubitemid 351787049)
-
(2008)
Neurodegenerative Diseases
, vol.5
, Issue.5
, pp. 268-276
-
-
Hoglund, K.1
Hansson, O.2
Buchhave, P.3
Zetterberg, H.4
Lewczuk, P.5
Londos, E.6
Blennow, K.7
Minthon, L.8
Wiltfang, J.9
-
30
-
-
33746003355
-
Cerebrospinal fluid tau and -amyloid in Alzheimer patients, disease controls and an age-matched random sample
-
DOI 10.1016/j.neurobiolaging.2005.06.005, PII S0197458005001867
-
Ibach B, Binder H, Dragon M, Poljansky S, Haen E, Schmitz E, Koch H, Putzhammer A, Kluenemann H, Wieland W, Hajak G (2006) Cerebrospinal fluid tau and beta-amyloid in Alzheimer patients, disease controls and an age-matched random sample. Neurobiol Aging 27, 1202-1211. (Pubitemid 44067302)
-
(2006)
Neurobiology of Aging
, vol.27
, Issue.9
, pp. 1202-1211
-
-
Ibach, B.1
Binder, H.2
Dragon, M.3
Poljansky, S.4
Haen, E.5
Schmitz, E.6
Koch, H.7
Putzhammer, A.8
Kluenemann, H.9
Wieland, W.10
Hajak, G.11
-
31
-
-
14944376675
-
Cerebrospinal fluid TAU protein and amyloid 42 in mild cognitive impairment: Prediction of progression to Alzheimer's disease and correlation with the neuropsychological examination
-
DOI 10.1080/13554790490896901
-
Ivanoiu A, Sindic CJ (2005) Cerebrospinal fluid tau protein and amyloid beta42 in mild cognitive impairment: Prediction of progression to Alzheimer's disease and correlation with the neuropsychological examination. Neurocase 11, 32-39. (Pubitemid 40372858)
-
(2005)
Neurocase
, vol.11
, Issue.1
, pp. 32-39
-
-
Ivanoiu, A.1
Sindic, C.J.M.2
-
32
-
-
14444269228
-
Longitudinal study of cerebrospinal fluid levels of tau, A1-40, and A1-42(43) in Alzheimer's disease: A study in Japan
-
DOI 10.1002/ana.410440108
-
Kanai M, Matsubara E, Isoe K, Urakami K, Nakashima K, Arai H, Sasaki H, Abe K, Iwatsubo T, Kosaka T, Watanabe M, Tomidokoro Y, Shizuka M, Mizushima K, Nakamura T, Igeta Y, Ikeda Y, Amari M, Kawarabayashi T, Ishiguro K, Harigaya Y, Wakabayashi K, Okamoto K, Hirai S, Shoji M (1998) Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: A study in Japan. Ann Neurol 44, 17-26. (Pubitemid 28323651)
-
(1998)
Annals of Neurology
, vol.44
, Issue.1
, pp. 17-26
-
-
Kanai, M.1
Matsubara, E.2
Isoe, K.3
Urakami, K.4
Nakashima, K.5
Arai, H.6
Sasaki, H.7
Abe, K.8
Iwatsubo, T.9
Kosaka, T.10
Watanabe, M.11
Tomidokoro, Y.12
Shizuka, M.13
Mizushima, K.14
Nakamura, T.15
Igeta, Y.16
Ikeda, Y.17
Amari, M.18
Kawarabayashi, T.19
Ishiguro, K.20
Harigaya, Y.21
Wakabayashi, K.22
Okamoto, K.23
Hirai, S.24
Shoji, M.25
more..
-
33
-
-
79954481450
-
Apo-E-4 allele in conjunction with A-42 and tau in CSF: Biomarker for Alzheimer's disease
-
Kandimalla RJ, Prabhakar S, Binukumar BK, Wani WY, Gupta N, Sharma DR, Sunkaria A, Grover VK, Bhardwaj N, Jain K, Gill KD (2011) Apo-E-4 allele in conjunction with A-42 and tau in CSF: Biomarker for Alzheimer's disease. Curr Alzheimer Res 8, 187-196.
-
(2011)
Curr Alzheimer Res
, vol.8
, pp. 187-196
-
-
Kandimalla, R.J.1
Prabhakar, S.2
Binukumar, B.K.3
Wani, W.Y.4
Gupta, N.5
Sharma, D.R.6
Sunkaria, A.7
Grover, V.K.8
Bhardwaj, N.9
Jain, K.10
Gill, K.D.11
-
34
-
-
0037335119
-
CSF tau protein and -amyloid (1-42) in Alzheimer's disease diagnosis: Discrimination from normal ageing and other dementias in the Greek population
-
DOI 10.1046/j.1468-1331.2003.00562.x
-
Kapaki E, Paraskevas GP, Zalonis I, Zournas C (2003) CSF tau protein and beta-amyloid (1-42) in Alzheimer's disease diagnosis: Discrimination from normal ageing and other dementias in the Greek population. Eur J Neurol 10, 119-128. (Pubitemid 36308205)
-
(2003)
European Journal of Neurology
, vol.10
, Issue.2
, pp. 119-128
-
-
Kapaki, E.1
Paraskevas, G.P.2
Zalonis, I.3
Zournas, C.4
-
35
-
-
33846448138
-
1-42 in idiopathic normal pressure hydrocephalus: A discrimination from Alzheimer's disease
-
DOI 10.1111/j.1468-1331.2006.01593.x
-
Kapaki EN, ParaskevasGP, Tzerakis NG, Sfagos C, Seretis A, Kararizou E, Vassilopoulos D (2007) Cerebrospinal fluid tau, phospho-tau181 and beta-amyloid1-42 in idiopathic normal pressure hydrocephalus: A discrimination from Alzheimer's disease. Eur J Neurol 14, 168-173. (Pubitemid 46148304)
-
(2007)
European Journal of Neurology
, vol.14
, Issue.2
, pp. 168-173
-
-
Kapaki, E.N.1
Paraskevas, G.P.2
Tzerakis, N.G.3
Sfagos, C.4
Seretis, A.5
Kararizou, E.6
Vassilopoulos, D.7
-
36
-
-
43249091150
-
Diagnostic value of CSF biomarker profile in frontotemporal lobar degeneration
-
DOI 10.1097/WAD.0b013e3181610fea, PII 0000209320080100000007
-
Kapaki E, Paraskevas GP, Papageorgiou SG, Bonakis A, Kalfakis N, Zalonis I, Vassilopoulos D (2008) Diagnostic value of CSF biomarker profile in frontotemporal lobar degeneration. Alzheimer Dis Assoc Disord 22, 47-53. (Pubitemid 351651397)
-
(2008)
Alzheimer Disease and Associated Disorders
, vol.22
, Issue.1
, pp. 47-53
-
-
Kapaki, E.1
Paraskevas, G.P.2
Papageorgiou, S.G.3
Bonakis, A.4
Kalfakis, N.5
Zalonis, I.6
Vassilopoulos, D.7
-
37
-
-
77952972200
-
Diagnostic impact of CSF biomarkers in a local hospital memory clinic
-
Kester MI, Boelaarts L, Bouwman FH, Vogels RL, Groot ER, van Elk EJ, Blankenstein MA (2010) Diagnostic impact of CSF biomarkers in a local hospital memory clinic. Dement Geriatr Cogn Disord 29, 491-497.
-
(2010)
Dement Geriatr Cogn Disord
, vol.29
, pp. 491-497
-
-
Kester, M.I.1
Boelaarts, L.2
Bouwman, F.H.3
Vogels, R.L.4
Groot, E.R.5
Van Elk, E.J.6
Blankenstein, M.A.7
-
38
-
-
67349214609
-
Improved discrimination of autopsyconfirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau (181P)
-
Koopman K, Le Bastard N, Martin JJ, Nagels G, De Deyn PP, Engelborghs S (2009) Improved discrimination of autopsyconfirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau (181P). Neurochem Int 55, 214-218.
-
(2009)
Neurochem Int
, vol.55
, pp. 214-218
-
-
Koopman, K.1
Le Bastard, N.2
Martin, J.J.3
Nagels, G.4
De Deyn, P.P.5
Engelborghs, S.6
-
39
-
-
77954981027
-
Alzheimer's Disease Neuroimaging Initiative. Comparing predictors of conversion and decline in mild cognitive impairment
-
Landau SM, Harvey D, Madison CM, Reiman EM, Foster NL, Aisen PS, Petersen RC, Shaw LM, Trojanowski JQ, Jack CR Jr (2010) Alzheimer's Disease Neuroimaging Initiative. Comparing predictors of conversion and decline in mild cognitive impairment. Neurology 20, 230-238.
-
(2010)
Neurology
, vol.20
, pp. 230-238
-
-
Landau, S.M.1
Harvey, D.2
Madison, C.M.3
Reiman, E.M.4
Foster, N.L.5
Aisen, P.S.6
Petersen, R.C.7
Shaw, L.M.8
Trojanowski, J.Q.9
Jack Jr., C.R.10
-
40
-
-
10744229989
-
Neurochemical diagnosis of Alzheimer's dementia by CSF A42, A42/A40 ratio and total tau
-
DOI 10.1016/S0197-4580(03)00086-1
-
Lewczuk P, Esselmann H, Otto M, Maler JM, Henkel AW, Henkel MK, Eikenberg O, Antz C, Krause WR, Reulbach U, Kornhuber J, Wiltfang J (2004) Neurochemical diagnosis of Alzheimer's dementia by CSF Abeta42, Abeta42/Abeta40 ratio and total tau. Neurobiol Aging 25, 273-281. (Pubitemid 38220961)
-
(2004)
Neurobiology of Aging
, vol.25
, Issue.3
, pp. 273-281
-
-
Lewczuk, P.1
Esselmann, H.2
Otto, M.3
Maler, J.M.4
Henkel, A.W.5
Henkel, M.K.6
Eikenberg, O.7
Antz, C.8
Krause, W.-R.9
Reulbach, U.10
Kornhuber, J.11
Wiltfang, J.12
-
41
-
-
0042972779
-
42
-
DOI 10.1001/archneur.60.9.1202
-
Maddalena A, Papassotiropoulos A, M?uller-Tillmanns B, Jung HH, Hegi T, Nitsch RM, Hock C (2003) Biochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to betaamyloid peptide 42. Arch Neurol 60, 1202-1206. (Pubitemid 37099624)
-
(2003)
Archives of Neurology
, vol.60
, Issue.9
, pp. 1202-1206
-
-
Maddalena, A.1
Papassotiropoulos, A.2
Muller-Tillmanns, B.3
Jung, H.H.4
Hegi, T.5
Nitsch, R.M.6
Hock, C.7
-
42
-
-
77956803451
-
A comparison of the diagnostic sensitivity of MRI, CBF-SPECT, FDG-PET and cerebrospinal fluid biomarkers for detecting Alzheimer's disease in a memory clinic
-
Morinaga A, Ono K, Ikeda T, Ikeda Y, Shima K, Noguchi- Shinohara M, Samuraki M, Yanase D, Yoshita M, Iwasa K, Mastunari I, Yamada M (2010) A comparison of the diagnostic sensitivity of MRI, CBF-SPECT, FDG-PET and cerebrospinal fluid biomarkers for detecting Alzheimer's disease in a memory clinic. Dement Geriatr Cogn Disord 30, 285-292.
-
(2010)
Dement Geriatr Cogn Disord
, vol.30
, pp. 285-292
-
-
Morinaga, A.1
Ono, K.2
Ikeda, T.3
Ikeda, Y.4
Shima, K.5
Noguchi- Shinohara, M.6
Samuraki, M.7
Yanase, D.8
Yoshita, M.9
Iwasa, K.10
Mastunari, I.11
Yamada, M.12
-
43
-
-
75749143930
-
Amyloid beta (1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease
-
Mulder C,VerweyNA, van der FlierWM,Bouwman FH,Kok A, van Elk EJ, Scheltens P, BlankensteinMA(2010) Amyloid beta (1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease. Clin Chem 56, 248-253.
-
(2010)
Clin Chem
, vol.56
, pp. 248-253
-
-
Mulder, C.1
Verwey, N.A.2
Van Der Flier, W.M.3
Bouwman, F.H.4
Kok, A.5
Van Elk, E.J.6
Scheltens, P.7
Blankenstein, M.A.8
-
44
-
-
25644432885
-
42 in cerebrospinal fluid of patients with progressive supranuclear palsy and corticobasal degeneration
-
DOI 10.1016/j.jns.2005.05.015, PII S0022510X0500198X
-
Noguchi M, Yoshita M, Matsumoto Y, Ono K, Iwasa K, YamadaM(2005) Decreased beta-amyloid peptide42 in cerebrospinal fluid of patients with progressive supranuclear palsy and corticobasal degeneration. J Neurol Sci 15, 61-65. (Pubitemid 41384015)
-
(2005)
Journal of the Neurological Sciences
, vol.237
, Issue.1-2
, pp. 61-65
-
-
Noguchi, M.1
Yoshita, M.2
Matsumoto, Y.3
Ono, K.4
Iwasa, K.5
Yamada, M.6
-
45
-
-
12944312683
-
181) in cerebrospinal fluid by the xMAP technology
-
DOI 10.1373/clinchem.2004.039347
-
Olsson A, Vanderstichele H, Andreasen N, De Meyer G, Wallin A, Holmberg B, Rosengren L, Vanmechelen E, Blennow K (2005) Simultaneous measurement of betaamyloid (1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology. Clin Chem 51, 336-345. (Pubitemid 40175803)
-
(2005)
Clinical Chemistry
, vol.51
, Issue.2
, pp. 336-345
-
-
Olsson, A.1
Vanderstichele, H.2
Andreasen, N.3
De Meyer, G.4
Wallin, A.5
Holmberg, B.6
Rosengren, L.7
Vanmechelen, E.8
Blennow, K.9
-
46
-
-
0037062351
-
Tau and A42 protein in CSF of patients with frontotemporal degeneration
-
Riemenschneider M, Wagenpfeil S, Diehl J, Lautenschlager N, Theml T, Heldmann B, Drzezga A, Jahn T, F?orstl H, Kurz A (2002) Tau and Abeta42 protein in CSF of patients with frontotemporal degeneration. Neurology 58, 1622-1628. (Pubitemid 34602892)
-
(2002)
Neurology
, vol.58
, Issue.11
, pp. 1622-1628
-
-
Riemenschneider, M.1
Wagenpfeil, S.2
Diehl, J.3
Lautenschlager, N.4
Theml, T.5
Heldmann, B.6
Drzezga, A.7
Jahn, T.8
Forstl, H.9
Kurz, A.10
-
47
-
-
70449348828
-
Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease
-
Roher AE, Maarouf CL, Sue LI, Hu Y, Wilson J, Beach TG (2009) Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease. Biomarkers 14, 493-501.
-
(2009)
Biomarkers
, vol.14
, pp. 493-501
-
-
Roher, A.E.1
Maarouf, C.L.2
Sue, L.I.3
Hu, Y.4
Wilson, J.5
Beach, T.G.6
-
48
-
-
0034942145
-
Clinical significance of neurobiochemical profiles in the lumbar cerebrospinal fluid of Alzheimer's disease patients
-
DOI 10.1007/s007020170091
-
R?osler N,Wichart I, JellingerKA(2001) Clinical significance of neurobiochemical profiles in the lumbar cerebrospinal fluid of Alzheimer's disease patients. J Neural Transm 108, 231- 246. (Pubitemid 32695765)
-
(2001)
Journal of Neural Transmission
, vol.108
, Issue.2
, pp. 231-246
-
-
Rosler, N.1
Wichart, I.2
Jellinger, K.A.3
-
49
-
-
2342551973
-
Amyloid (1-42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease
-
Schoonenboom NS, Pijnenburg YA, Mulder C, Rosso SM, Van Elk EJ, Van Kamp GJ, Van Swieten JC, Scheltens P (2004) Amyloid beta(1-42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease. Neurology 11, 1580-1584. (Pubitemid 38608199)
-
(2004)
Neurology
, vol.62
, Issue.9
, pp. 1580-1584
-
-
Schoonenboom, N.S.M.1
Pijnenburg, Y.A.L.2
Mulder, C.3
Rosso, S.M.4
Van Elk, E.-J.5
Van Kamp, G.J.6
Van Swieten, J.C.7
Scheltens, Ph.8
-
50
-
-
19644396893
-
Differences and similarities between two frequently used assays for amyloid 42 in cerebrospinal fluid
-
DOI 10.1373/clinchem.2005.048629
-
Schoonenboom NS, Mulder C, Vanderstichele H, Pijnenburg YA, Van Kamp GJ, Scheltens P, Mehta PD, Blankenstein MA (2005) Differences and similarities between two frequently used assays for amyloid beta 42 in cerebrospinal fluid. Clin Chem 51, 1057-1060. (Pubitemid 40740899)
-
(2005)
Clinical Chemistry
, vol.51
, Issue.6
, pp. 1057-1060
-
-
Schoonenboom, N.S.M.1
Mulder, C.2
Vanderstichele, H.3
Pijnenburg, Y.A.L.4
Van Kamp, G.J.5
Scheltens, P.6
Mehta, P.D.7
Blankenstein, M.A.8
-
51
-
-
77956469313
-
Confirmation rate of blinded (99m)Tc-SPECT compared to neurochemical dementia biomarkers in CSF in patients with Alzheimer disease
-
Schmidt D, Zimmermann R, Lewczuk P, Schaller G, Degirmenci U, Kreil S, Wiltfang J, Kuwert T, Kornhuber J, Weih M (2010) Confirmation rate of blinded (99m)Tc-SPECT compared to neurochemical dementia biomarkers in CSF in patients with Alzheimer disease. J Neural Transm 117, 1111- 1114.
-
(2010)
J Neural Transm
, vol.117
, pp. 1111-1114
-
-
Schmidt, D.1
Zimmermann, R.2
Lewczuk, P.3
Schaller, G.4
Degirmenci, U.5
Kreil, S.6
Wiltfang, J.7
Kuwert, T.8
Kornhuber, J.9
Weih, M.10
-
52
-
-
65249159879
-
Alzheimer's Disease Neuroimaging Initiative. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
-
Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter W, Lee VM, Trojanowski JQ (2009) Alzheimer's Disease Neuroimaging Initiative. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann Neurol 65, 403-413.
-
(2009)
Ann Neurol
, vol.65
, pp. 403-413
-
-
Shaw, L.M.1
Vanderstichele, H.2
Knapik-Czajka, M.3
Clark, C.M.4
Aisen, P.S.5
Petersen, R.C.6
Blennow, K.7
Soares, H.8
Simon, A.9
Lewczuk, P.10
Dean, R.11
Siemers, E.12
Potter, W.13
Lee, V.M.14
Trojanowski, J.Q.15
-
53
-
-
57349191820
-
Interest of CSF beta-amyloid1-42 and t-tau protein level determinations for the diagnosis of Alzheimer's disease
-
Smach MA, Charfeddine B, Lammouchi T, Dridi H, Ben Othman L, Bennamou S, Limem K (2008) Interest of CSF beta-amyloid1-42 and t-tau protein level determinations for the diagnosis of Alzheimer's disease. Ann Biol Clin (Paris) 66, 531-535.
-
(2008)
Ann Biol Clin (Paris)
, vol.66
, pp. 531-535
-
-
Ma, S.1
Charfeddine, B.2
Lammouchi, T.3
Dridi, H.4
Ben Othman, L.5
Bennamou, S.6
Limem, K.7
-
54
-
-
0034282184
-
Relationship between apoE genotype and CSF beta-amyloid (1-42) and tau in patients with probable and definite Alzheimer's disease
-
Tapiola T, Pirttil?a T, Mehta PD, Alafuzofff I, Lehtovirta M, Soininen H (2000) Relationship between apoE genotype and CSF beta-amyloid (1-42) and tau in patients with probable and definite Alzheimer's disease. Neurobiol Aging 21, 735-740.
-
(2000)
Neurobiol Aging
, vol.21
, pp. 735-740
-
-
Tapiola, T.1
Pirttila, T.2
Mehta, P.D.3
Alafuzofff, I.4
Lehtovirta, M.5
Soininen, H.6
-
55
-
-
80054838966
-
Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand
-
Thaweepoksomboon J, Senanarong V, Poungvarin N, Chakorn T, Siwasariyanon N, Washirutmangkur L, Udompunthuruk S (2011) Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand. J Med Assoc Thai 94(Suppl 1), S77-S83.
-
(2011)
J Med Assoc Thai
, vol.94
, Issue.SUPPL. 1
-
-
Thaweepoksomboon, J.1
Senanarong, V.2
Poungvarin, N.3
Chakorn, T.4
Siwasariyanon, N.5
Washirutmangkur, L.6
Udompunthuruk, S.7
-
56
-
-
33845713197
-
(181P) assay for discrimination between Alzheimer's disease and dementia with Lewy bodies
-
DOI 10.1515/CCLM.2006.258
-
Vanderstichele H, De Vreese K, Blennow K, Andreasen N, Sindic C, IvanoiuA, Hampel H, B?urger K, Parnetti L, Lanari A, Padovani A, DiLuca M, Bl?aser M, Olsson AO, Pottel H, Hulstaert F, Vanmechelen E (2006) Analytical performance and clinical utility of the INNOTEST PHOSPHO-TAU181P assay for discrimination between Alzheimer's disease and dementia with Lewy bodies. Clin Chem Lab Med 44, 1472- 1480. (Pubitemid 44967698)
-
(2006)
Clinical Chemistry and Laboratory Medicine
, vol.44
, Issue.12
, pp. 1472-1480
-
-
Vanderstichele, H.1
De Vreese, K.2
Blennow, K.3
Andreasen, N.4
Sindic, C.5
Ivanoiu, A.6
Hampel, H.7
Burger, K.8
Parnetti, L.9
Lanari, A.10
Padovani, A.11
Diluca, M.12
Blaser, M.13
Ohrfelt Olsson, A.14
Pottel, H.15
Hulstaert, F.16
Vanmechelen, E.17
-
57
-
-
59849112270
-
Combined CSF tau, p-tau181 and amyloid-beta 38/40/42 for diagnosing Alzheimer's disease
-
Welge V, Fiege O, Lewczuk P, Mollenhauer B, Esselmann H, Klafki HW, Wolf S, Trenkwalder C, Otto M, Kornhuber J, Wiltfang J, Bibl M (2009) Combined CSF tau, p-tau181 and amyloid-beta 38/40/42 for diagnosing Alzheimer's disease. J Neural Transm 116, 203-212.
-
(2009)
J Neural Transm
, vol.116
, pp. 203-212
-
-
Welge, V.1
Fiege, O.2
Lewczuk, P.3
Mollenhauer, B.4
Esselmann, H.5
Klafki, H.W.6
Wolf, S.7
Trenkwalder, C.8
Otto, M.9
Kornhuber, J.10
Wiltfang, J.11
Bibl, M.12
-
58
-
-
77949425172
-
Cerebrospinal fluid tau and ptau (181) increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease
-
Fagan AM, Mintun MA, Shah AR, Aldea P, Roe CM, Mach RH, Marcus D, Morris JC, Holtzman DM (2009) Cerebrospinal fluid tau and ptau (181) increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease.EMBO Mol Med 1, 371-380.
-
(2009)
EMBO Mol Med
, vol.1
, pp. 371-380
-
-
Fagan, A.M.1
Ma, M.2
Shah, A.R.3
Aldea, P.4
Roe, C.M.5
Mach, R.H.6
Marcus, D.7
Morris, J.C.8
Holtzman, D.M.9
-
59
-
-
69449085355
-
Relationship of cerebrospinal fluid markers to 11CPiB and 18F-FDDNP binding
-
Tolboom N, van der Flier WM, Yaqub M, Boellaard R, Verwey NA, Blankenstein MA, Windhorst AD, Scheltens P, Lammertsma AA, van Berckel BN (2009) Relationship of cerebrospinal fluid markers to 11CPiB and 18F-FDDNP binding. J Nucl Med 50, 1464-1461.
-
(2009)
J Nucl Med
, vol.50
, pp. 1464-1461
-
-
Tolboom, N.1
Van Der Flier, W.M.2
Yaqub, M.3
Boellaard, R.4
Verwey, N.A.5
Ma, B.6
Windhorst, A.D.7
Scheltens, P.8
Lammertsma, A.A.9
Van Berckel, B.N.10
-
60
-
-
67349227896
-
Beta amyloid in Alzheimer's disease: Increased deposition in brain is reflected in reduced concentration in cerebrospinal fluid
-
Grimmer T, Riemenschneider M, F?orstl H, Henriksen G, Klunk WE, Mathis CA, Shiga T,Wester HJ, Kurz A, Drzezga A (2009) Beta amyloid in Alzheimer's disease: Increased deposition in brain is reflected in reduced concentration in cerebrospinal fluid. Biol Psychiatry 65, 927-934.
-
(2009)
Biol Psychiatry
, vol.65
, pp. 927-934
-
-
Grimmer, T.1
Riemenschneider, M.2
Forstl, H.3
Henriksen, G.4
Klunk, W.E.5
Mathis, C.A.6
Shiga, T.7
Wester, H.J.8
Kurz, A.9
Drzezga, A.10
-
61
-
-
70350152831
-
Relationships between biomarkers in aging and dementia
-
Jagust WJ, Landau SM, Shaw LM, Trojanowski JQ, Koeppe RA, Reiman EM, Foster NL, Petersen RC,WeinerMW, Price JC, Mathis CA (2009) Relationships between biomarkers in aging and dementia. Neurology 73, 1193-1199.
-
(2009)
Neurology
, vol.73
, pp. 1193-1199
-
-
Jagust, W.J.1
Landau, S.M.2
Shaw, L.M.3
Trojanowski, J.Q.4
Koeppe, R.A.5
Reiman, E.M.6
Foster, N.L.7
Petersen, R.C.8
Weiner, M.W.9
Price, J.C.10
Mathis, C.A.11
-
62
-
-
62449262536
-
Cerebrospinal fluid -amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain
-
Tapiola T, Alafuzoff I, Herukka SK, Parkkinen L, Hartikainen P, Soininen H, Pirttil?a T (2009) Cerebrospinal fluid -amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Arch Neurol 66, 382-389.
-
(2009)
Arch Neurol
, vol.66
, pp. 382-389
-
-
Tapiola, T.1
Alafuzoff, I.2
Herukka, S.K.3
Parkkinen, L.4
Hartikainen, P.5
Soininen, H.6
Pirttila, T.7
-
63
-
-
1542313783
-
Core biological marker candidates of Alzheimer's disease - Perspectives for diagnosis, prediction of outcome and reflection of biological activity
-
DOI 10.1007/s00702-003-0065-z, Modelling Alzheimers Dementia
-
Hampel H, Mitchell A, Blennow K, Frank RA, Brettschneider S, Weller L, Moller HJ (2004) Core biological marker candidates of Alzheimer's disease-perspectives for diagnosis, prediction of outcome and reflection of biological activity. J Neural Transm 111, 247-272. (Pubitemid 38316604)
-
(2004)
Journal of Neural Transmission
, vol.111
, Issue.3
, pp. 247-272
-
-
Hampel, H.1
Mitchell, A.2
Blennow, K.3
Frank, R.A.4
Brettschneider, S.5
Weller, L.6
Moller, H.-J.7
-
64
-
-
77952202260
-
CSF biomarkers predict a more malignant outcome in Alzheimer disease
-
Wallin AK, Blennow K, Zetterberg H (2010) CSF biomarkers predict a more malignant outcome in Alzheimer disease. Neurology 74, 1531-1537.
-
(2010)
Neurology
, vol.74
, pp. 1531-1537
-
-
Wallin, A.K.1
Blennow, K.2
Zetterberg, H.3
-
65
-
-
0025863618
-
Neuropathological stageing of Alzheimer-related changes
-
Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82, 239-259.
-
(1991)
Acta Neuropathol
, vol.82
, pp. 239-259
-
-
Braak, H.1
Braak, E.2
-
66
-
-
79952747862
-
Alzheimer's disease
-
Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E (2011) Alzheimer's disease. Lancet 377, 1019-1031.
-
(2011)
Lancet
, vol.377
, pp. 1019-1031
-
-
Ballard, C.1
Gauthier, S.2
Corbett, A.3
Brayne, C.4
Aarsland, D.5
Jones, E.6
-
67
-
-
0037135111
-
The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
-
DOI 10.1126/science.1072994
-
Hardy (2002) the amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297, 353-356. (Pubitemid 34790756)
-
(2002)
Science
, vol.297
, Issue.5580
, pp. 353-356
-
-
Hardy, J.1
Selkoe, D.J.2
-
68
-
-
84863440187
-
Biomarkers in Alzheimer's disease
-
Riverol M, L'opez OL (2011) Biomarkers in Alzheimer's disease. Front Neurol 2, 46.
-
(2011)
Front Neurol
, vol.2
, pp. 46
-
-
Riverol, M.1
L'Opez, O.L.2
-
69
-
-
84892918273
-
Alzheimer's Disease Neuroimaging Initiative. Comparing PET imaging and CSF measurements of A
-
doi: 10.1002/ana.23908
-
Landau SM, Lu M, Joshi AD, Pontecorvo M, Mintun MA, Trojanowski JQ, Shaw LM, Jagust WJ (2013) Alzheimer's Disease Neuroimaging Initiative. Comparing PET imaging and CSF measurements of A-. Ann Neurol, doi: 10.1002/ana.23908
-
(2013)
Ann Neurol
-
-
Landau, S.M.1
Lu, M.2
Joshi, A.D.3
Pontecorvo, M.4
Ma, M.5
Trojanowski, J.Q.6
Shaw, L.M.7
Jagust, W.J.8
-
70
-
-
53849132759
-
PET amyloid ligand 11C PIB uptake and cerebrospinal fluid beta-amyloid in mild cognitive impairment
-
Koivunen J, Pirttil?a T, Kemppainen N, Aalto S, Herukka SK, Jauhianen AM, H?anninen T, Hallikainen M, N°agren K, Rinne JO, Soininen H (2008) PET amyloid ligand 11C. PIB uptake and cerebrospinal fluid beta-amyloid in mild cognitive impairment. Dement Geriatr Cogn Disord 26, 378-383.
-
(2008)
Dement Geriatr Cogn Disord
, vol.26
, pp. 378-383
-
-
Koivunen, J.1
Pirttila, T.2
Kemppainen, N.3
Aalto, S.4
Herukka, S.K.5
Jauhianen, A.M.6
Hanninen, T.7
Hallikainen, M.8
Nagren, K.9
Rinne, J.O.10
Soininen, H.11
-
71
-
-
69449085355
-
Relationship of cerebrospinal fluid markers to 11C-PiB and 18F-FDDNP binding
-
Tolboom N, van der Flier WM, Yaqub M, Boellaard R, Verwey NA, Blankenstein MA, Windhorst AD, Scheltens P, Lammertsma AA, van Berckel BN (2009) Relationship of cerebrospinal fluid markers to 11C-PiB and 18F-FDDNP binding. J Nucl Med 50, 1464.
-
(2009)
J Nucl Med
, vol.50
, pp. 1464
-
-
Tolboom, N.1
Van Der Flier, W.M.2
Yaqub, M.3
Boellaard, R.4
Verwey, N.A.5
Blankenstein, M.A.6
Windhorst, A.D.7
Scheltens, P.8
Lammertsma, A.A.9
Van Berckel, B.N.10
-
72
-
-
77954706306
-
Serial MRI and CSF biomarkers in normal aging, MCI, and -ADSEQ
-
Vemuri (2010) Serial MRI and CSF biomarkers in normal aging, MCI, and AD. Neurology 75, 143-151.
-
(2010)
Neurology
, vol.75
, pp. 143-151
-
-
-
73
-
-
84872481287
-
Perspectives for multimodal neurochemical and imaging biomarkers in Alzheimer's disease
-
Teipel SJ, Sabri O, Grothe M, Barthel H, Prvulovic D, Buerger K, Bokde AL, Ewers M, Hoffmann W, Hampel H (2013) Perspectives for multimodal neurochemical and imaging biomarkers in Alzheimer's disease. J Alzheimers Dis 33, S329-S347.
-
(2013)
J Alzheimers Dis
, vol.33
-
-
Teipel, S.J.1
Sabri, O.2
Grothe, M.3
Barthel, H.4
Prvulovic, D.5
Buerger, K.6
Bokde, A.L.7
Ewers, M.8
Hoffmann, W.9
Hampel, H.10
|